CSF2 and neoplasm: Analogous to previous studies, this injectable inorganic scaffold extended the release of the embedded GM-CSF, CpG and model antigens to recruit and educate host immune cells, leading to significant production of systemic antibodies and cytotoxic T cells that effectively delayed the tumor growth (Kim et al., 2015).